Cargando…

Treatment of obstetric hemorrhage with recombinant activated factor VII

Detalles Bibliográficos
Autores principales:	Czuprynski, P, Michalska, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084319/ http://dx.doi.org/10.1186/cc7597

Ejemplares similares

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Two years experience with low-dose recombined activated factor VII treatment of non-haemophilic patients
por: Michalska, G, et al.
Publicado: (2006)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Recombinant activated factor VII: does it really save lives?
por: Edke, U
Publicado: (2009)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes
por: Liebl, M, et al.
Publicado: (2007)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
por: Spivey, M, et al.
Publicado: (2009)

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007)

Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
por: Aggarwal, Anita, et al.
Publicado: (2004)

Life-threatening hemorrhage in neonates and children: treatment with activated recombinant factor VII
por: Fischer, D, et al.
Publicado: (2003)

Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage
por: Park, Soon Chang, et al.
Publicado: (2017)

Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis
por: Mandal, S. K., et al.
Publicado: (2012)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

The use of activated recombinant coagulation factor VII in patients undergoing major reconstruction surgery for traumatic fracture pelvis or pelvis and acetabulum: a double-blind, randomised, placebo-controlled trial
por: Raobaikady, R, et al.
Publicado: (2005)

Recombinant human activated factor VII in postpartum hemorrhagic shock: the dark side
por: van Veen, E. J. W., et al.
Publicado: (2007)

Thromboembolic risks of recombinant factor VIIa use in warfarin-associated intracranial hemorrhage
por: Chou, S, et al.
Publicado: (2011)

Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis
por: Khoulani, Dania, et al.
Publicado: (2014)

Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
por: Heslet, Lars, et al.
Publicado: (2006)

Recombinant activated factor VII in a patient with intracranial hemorrhage and severe thrombocytopenia
por: Ansari, Amir M., et al.
Publicado: (2021)

Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock
por: Sobieszczyk, S, et al.
Publicado: (2003)

Effectiveness and safety of recombinant activated factor
por: Echarri González, G, et al.
Publicado: (2006)

Successful hemostasis in refractory alveolar hemorrhage using low-dose recombinant activated factor VII
por: Selickman, John, et al.
Publicado: (2022)

Dose effects of recombinant human IL-11 on the systemic hemodynamic function in hemorrhagic shock
por: Honma, K, et al.
Publicado: (2007)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer
por: Esper, Raúl Carrillo, et al.
Publicado: (2014)

Acute renal failure in obstetrics: risk factors and outcome
por: Haddad, Z, et al.
Publicado: (2007)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Factors related to the outcome of ICU patients with celebral hemorrhage
por: Georgiadou, M, et al.
Publicado: (2015)

Predicting response to recombinant activated factor VIIa administration in the critically ill
por: Pugh, R, et al.
Publicado: (2008)

Diagnosis and treatment of subarachnoid hemorrhage-induced vasospasm
por: Frosini, C, et al.
Publicado: (2009)

Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016)

The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia
por: Poon, Man-Chiu
Publicado: (2021)

Incidence, risk factors and outcome of venous thromboembolism in critically ill obstetric patients
por: Kaddour, C, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6l2n6aftjp3sueh86tk7k04hs3